Skip to main content
. 2020 Nov 30;11:603312. doi: 10.3389/fimmu.2020.603312

Table 2.

New potential targets of emerging anti-asthma therapies.

New potential targets New potential drugs Molecular mechanisms of action Effects in the control of severe asthma
TSLP Tezepelumab Prevention of TSLP binding to its receptor complex ↓ Blood eosinophils
↓ FeNO
↓ Exacerbations
↑ FEV1
IL-33 REGN3500 Prevention of IL-33 binding to ST2 receptor ↑ Quality of life and symptom control
PGD2 Fevipiprant Selective antagonism of CRTH2 receptor Weak FEV1 increase